Access cutting-edge avian influenza treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access avian influenza specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related avian influenza treatment provided free
The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subtypes).
Sponsor: AstraZeneca
Check if you qualify for this avian influenza clinical trial in Chicago, IL
If you're searching for avian influenza treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced avian influenza specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.